China
Asia gyms: Muscling through the mire
Fitness centers have continued to woo investors during COVID-19 despite patchy progress in the reopening of gyms and difficult-to-digitize business models
China's Burning Rock soars on debut after $222m US IPO
Burning Rock Biotech, a venture capital-backed, China-based provider of genetic testing services used in cancer diagnosis, rose 49% on its trading debut following a $222.8 million US IPO.
Chinese instant food brand Baijia raises $28m
Chinese instant food brand Baijia Food has raised RMB200 million ($28 million) in Series B funding led by GL Ventures, the venture capital arm of Hillhouse Capital.
Matrix China raises $750m for Fund VI
Matrix Partners China has raised $750 million for its sixth venture capital fund for deployment in early-stage opportunities across the internet and mobile internet, financial services, healthcare, and enterprises services spaces.
CPE, Mirae lead $100m Series B for China's JW Therapeutics
JW Therapeutics, a China cancer treatment specialist established by Bristol Myers Squibb-owned Juno Therapeutics and China’s WuXi AppTec, has received $100 million in Series B funding.
China social e-commerce player Tongcheng Life gets $200m
Tongcheng Life, a social e-commerce business incubated by online travel agency Tongcheng-Elong, has raised a $200 million Series C round led by Joyy, previously known as YY, a US-listed video-based social media platform.
Gaorong backs China enterprise software player QuadTalent
Gaorong Capital has led a $20 million Series A round for Chinese enterprise software start-up QuadTalent at a post-money valuation of nearly $200 million.
China chip design company Eswin raises $283m
Beijing-based chip design company Eswin Technology Group has raised a RMB2 billion ($283 million) Series B round led by IDG Capital and Legend Capital.
China auto parts supplier Mancando gets $57m Series B
Mancando, a Chinese automotive parts supplier, has raised a RMB400 million ($56.6 million) Series B round led by Huaxing Growth Capital. Xiang He Capital, Axiom Asia Private Capital and Oriza FoF also took part.
Cathay Capital raises $120m for China smart energy fund
Cathay Capital Private Equity has raised RMB820 million ($120 million) for its debut China smart energy fund, securing commitments from ALIAD, the venture capital arm of French industrial gases producer Air Liquide Group, among other investors.
Geely EV rental spin-out secures $97m Series A
Xiaolinggou Chuxing, the electric vehicle (EV) rental unit of Chinese carmaker Geely Auto Group, has raised RMB688 million ($97 million) in a Series A funding.
CMC leads Series C for Chinese B2B apparel player
Yishou, a Chinese B2B e-commerce platform specializing in apparel, has raised $40 million in Series C funding led by CMC Capital. Huaxing Growth Capital also took part in the round.
China's Dada Nexus trades flat after $322m US IPO
Dada Nexus, a Chinese last-mile delivery platform backed by the likes of JD.com, Walmart, Sequoia Capital China, and DST Global, traded flat on its NASDAQ debut following a $320 million IPO.
Chinese drug developer Everest secures $310m Series C
Everest Medicines, a China-based biopharmaceutical company, has raised $310 million in Series C funding across two tranches.
SK Telecom leads Series C for China cloud services player
Bespin Global, a Seoul and Beijing-based cloud management services provider, has raised RMB530 million ($74.6 million) in a Series C round from SK Telecom and existing investor DY Holdings.
China EV: End of the road?
Challenged by the arrival of Tesla, the removal of subsidies, and the coronavirus outbreak, China’s independent electric vehicle makers are at a point of reckoning. Many will stumble
Deal focus: Reworld turns gamers into creators
China's Reworld has a technology that lowers barriers to entry in online game design, allowing anyone to become a creator. Joy Capital is backing the company to take user-generated content to another level
PE-backed Chinese pop toy retailer pursues Hong Kong IPO
Pop Mart International Group, China’s largest fashion toy retailer, has filed for a Hong Kong IPO. Sequoia Capital China, Loyal Valley Capital and Huaxing Growth Fund are its three largest institutional backers.
Fund focus: China's Glory wins VC backing
Glory Ventures counts several larger Chinese peers among the LPs in its latest renminbi and US dollar-denominated funds. They all want a glimpse of the firm’s deep technology pipeline
Q&A: ClearVue Partners' Harry Hui
Harry Hui, founder of ClearVue Partners, explains how this week’s investment in car wash operator 1km reveals an omni-channel approach to China able to carve through COVID-19
GGV leads round for Chinese community group buying business
Shihuituan, a China-based community group buying platform also known as Nice Tuan, has raised $81.4 million in an extended Series C round led by GGV Capital.
China's Didi raises $500m for autonomous driving unit
SoftBank Corporation’s second Vision Fund – which currently comprises balance sheet capital from its parent – has led a $500 million funding round for the autonomous driving technology business of Chinese ride-hailing giant Didi Chuxing.
Shiyu leads $276m round for China's Mabwell Biotech
Mabwell Biotech, a Chinese drug developer with one treatment cleared for production, has raised RMB1.97 billion ($276 million) in Series A funding across two tranches led by specialist healthcare investor Shiyu Capital.
Sequoia leads $30m round for China's Atom Bioscience
Chinese drug developer Jiangsu Atom Bioscience & Pharmaceutical has raised $30 million in Series B funding led by Sequoia Capital China and Hong Kong-listed Livzon Pharmaceutical Group.